Susquehanna International Group, LLP Pliant Therapeutics, Inc. Call Options Transaction History

Susquehanna International Group, LLP

12 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	SELL	$10.52 - $14.35 $483,920 - $660,100	-46,000 Reduced 61.25%	29,100 $326,000
Q2 2024 Aug 15, 2024	SELL	$10.58 - $15.61 $70,886 - $104,587	-6,700 Reduced 8.19%	75,100 $807,000
Q1 2024 May 07, 2024	BUY	$14.14 - $19.59 $982,730 - $1.36 Million	69,500 Added 565.04%	81,800 $1.22 Million
Q4 2023 Feb 14, 2024	SELL	$12.85 - $19.15 $57,825 - $86,175	-4,500 Reduced 26.79%	12,300 $222,000
Q3 2023 Nov 14, 2023	SELL	$14.58 - $20.15 $1.92 Million - $2.65 Million	-131,500 Reduced 88.67%	16,800 $291,000
Q2 2023 Aug 11, 2023	BUY	$18.12 - $30.56 $655,944 - $1.11 Million	36,200 Added 32.29%	148,300 $2.69 Million
Q1 2023 May 16, 2023	BUY	$18.73 - $36.26 $528,186 - $1.02 Million	28,200 Added 33.61%	112,100 $2.98 Million
Q4 2022 Feb 14, 2023	SELL	$17.0 - $25.43 $215,900 - $322,961	-12,700 Reduced 13.15%	83,900 $1.62 Million
Q3 2022 Nov 14, 2022	BUY	$7.67 - $24.23 $319,072 - $1.01 Million	41,600 Added 75.64%	96,600 $2.02 Million
Q2 2022 Aug 15, 2022	BUY	$4.11 - $8.75 $226,050 - $481,250	55,000 New	55,000 $441,000
Q1 2022 May 16, 2022	SELL	$7.01 - $14.1 $144,406 - $290,460	-20,600 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$12.27 - $18.26 $252,762 - $376,156	20,600 New	20,600 $278,000

168

63.2M

245K

373K

Ticker PLRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,682,000
Market Cap $605M
Description
Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. Its lead product candidate is PLN-74809, an oral small-molecule dual selective inhibitor of avß6 and avß1 integrins, which is in three Phase 2a tri...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.